AV

Ashish Verma

Active Director Director DIN 10447436
DIN 10447436 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Ashish Verma

Data last updated:

Ashish Verma is a Director at Nayyam Pharma Private Limited (since 2023). Nayyam Pharma Private Limited reported revenue of ₹50,393 (FY 2025).

DIN 10447436
Primary Designation Director
First Appointment 30 Dec 2023
Oldest Company Age 2 yrs
Largest company Nayyam Pharma Private Limited · ₹50,393 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nayyam Pharma Private Limited U47721MP2023PTC069175
Director30 Dec 20232023₹50,393 (FY 2025)Active

Board colleagues of Ashish Verma

NameDINCompanyDesignation
Kalpana Mishra10447438Nayyam Pharma Private LimitedDirector
Poonam Rawat10447437Nayyam Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nayyam Pharma Private Limited
Premium access

Shareholding and investment profile for Ashish Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Verma

Ashish Verma currently holds 1 directorship: Nayyam Pharma Private Limited (Director, since 30 Dec 2023, revenue ₹50,393 (FY 2025)).

Ashish Verma was first appointed on 30 Dec 2023 as Director at Nayyam Pharma Private Limited.

The current boards of Ashish Verma's companies include Kalpana Mishra (Nayyam Pharma Private Limited), Poonam Rawat (Nayyam Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available